Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Rescriptor (Delavirdine Mesylate) Tablets
Company: Agouron Pharmaceuticals, Inc.
Application No.:  020705s008
Approval Date: 05/16/2001


Date created:  July 09, 2007

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.